Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice

Human Molecular Genetics

Volumn 13, Issue 13, 2004, Pages 1321-1331

  Tournoy, Jos ^a,c   Bossuyt, Xavier ^b   Snellinx, An ^a,c   Regent, Marleen ^a,c   Garmyn, Marian ^a   Serneels, Lutgarde ^a,c   Saftig, Paul ^d   Craessaerts, Katleen ^a,c   De Strooper, Bart ^a,c   Hartmann, Dieter ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTINUCLEAR ANTIBODY; BETA CATENIN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; IMMUNOGLOBULIN; NOTCH RECEPTOR; PRESENILIN 1; PRESENILIN 2; WNT PROTEIN;

ALLELE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DERMATITIS; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; GENE INACTIVATION; GENE LOSS; GLOMERULONEPHRITIS; HYPERGAMMAGLOBULINEMIA; IMMUNE COMPLEX DEPOSITION; KERATITIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; SEBORRHEIC KERATOSIS; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTIBODIES, ANTINUCLEAR; ASPARTIC ENDOPEPTIDASES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; ENDOPEPTIDASES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATOSIS, SEBORRHEIC; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; PRESENILIN-1; PRESENILIN-2; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH; WNT PROTEINS;

EID: 3242713169     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh151     Document Type: Article

References (59)

1. Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. (2002) PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem., 277, 39 062-39 065.
2. Esler, W.P., Kimberly, W.T., Ostaszewski, B.L., Ye, W., Diehl, T.S., Selkoe, D.J. and Wolfe, M.S. (2002) Activity-dependent isolation of the presenilin- gamma-secretase complex reveals nicastrin and a gamma substrate. Proc. Natl Acad. Sci. USA, 99, 2720-2725.
3. Kopan, R. and Goate, A. (2002) Aph-2/nicastrin: an essential component of gamma-secretase and regulator of notch signaling and presenilin localization. Neuron, 33, 321-324.
4. Kimberly, W.T., LaVoie, M.J., Ostaszewski, B.L., Ye, W., Wolfe, M.S. and Selkoe, D.J. (2003) Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl Acad. Sci. USA, 100, 6382-6387.
5. De Strooper, B. (2003) Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex. Neuron, 38, 9-12.
6. Edbauer, D., Winkler, E., Regula, J.T., Pesold, B., Steiner, H. and Haass, C. (2003) Reconstitution of gamma-secretase activity. Nat. Cell. Biol., 5, 486-488.
7. De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K. and Van Leuven, F. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature, 391, 387-390.
8. De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J.S., Schroeter, E.H., Schrijvers, V., Wolfe, M.S., Ray, W.J. et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of notch intracellular domain. Nature, 398, 518-522.
9. Borchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport, F., Ratovitsky, T., Prada, C. M., Kim, G., Seekins, S., Yager, D. et al. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron, 17, 1005-1013.
10. Murayama, M., Tanaka, S., Palacino, J., Murayama, O., Honda, T., Sun, X., Yasutake, K., Nihonmatsu, N., Wolozin, B. and Takashima, A. (1998) Direct association of presenilin-1 with beta-catenin. FEBS Lett., 433, 73-77.
11. Baki, L., Marambaud, P., Efthimiopoulos, S., Georgakopoulos, A., Wen, P., Cui, W., Shioi, J., Koo, E., Ozawa, M., Friedrich, V.L., Jr et al. (2001) Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc. Natl Acad. Sci. USA, 98, 2381-2386.
12. Marambaud, P., Shioi, J., Serban, G., Georgakopoulos, A., Sarner, S., Nagy, V., Baki, L., Wen, P., Efthimiopoulos, S., Shao, Z. et al. (2002) A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J., 21, 1948-1956.
13. Xia, X., Qian, S., Soriano, S., Wu, Y., Fletcher, A.M., Wang, X.J., Koo, E.H., Wu, X. and Zheng, H. (2001) Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc. Natl Acad. Sci. USA, 98, 10863-10868.
14. Soriano, S., Kang, D.E., Fu, M., Pestell, R., Chevallier, N., Zheng, H. and Koo, E.H. (2001) Presenilin 1 negatively regulates beta-catenin/LEF signaling independently of APP and notch processing. J. Cell Biol., 152, 785-794.
15. Shen, J., Bronson, R.T., Chen, D.F., Xia, W., Selkoe, D.J. and Tonegawa, S. (1997) Skeletal and CNS defects in presenilin-1-deficient mice. Cell, 89, 629-639.
16. Hartmann, D., De Strooper, B. and Saftig, P. (1999) Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly. Curr. Biol., 9, 719-727.
17. Wong, P.C., Zheng, H., Chen, H., Becher, M.W., Sirinathsinghji, D.J., Trumbauer, M.E., Chen, H.Y., Price, D.L., Van der Ploeg, L.H. and Sisodia, S.S. (1997) Presenilin 1 is required for notchl and DII1 expression in the paraxial mesoderm. Nature, 387, 288-292.
18. Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L., Schrijvers, V., Checler, F., Vanderstichele, H. et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl Acad. Sci. USA, 96, 11872-11877.
19. Donoviel, D.B., Hadjantonakis, A.K., Ikeda, M., Zheng, H., Hyslop, P.S. and Bernstein, A. (1999) Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev., 13, 2801-2810.
20. Pear, W.S. and Radtke, F. (2003) Notch signaling in lymphopoiesis. Semin. Immunol., 15, 69-79.
21. Ohishi, K., Katayama, N., Shiku, H., Varnum-Finney, B. and Bernstein, I.D. (2003) Notch signalling in hematopoiesis. Semin. Cell. Dev. Biol., 14, 143-150.
22. Mori, S., Kadokawa, Y., Hoshinaga, K. and Marunouchi, T. (2003) Sequential activation of notch family receptors during mouse spermatogenesis. Dev. Growth Differ., 45, 7-13.
23. Duvic, B., Hoffmann, J.A., Meister, M. and Royet, J. (2002) Notch signaling controls lineage specification during Drosophila larval hematopoiesis. Curr. Biol., 12, 1923-1927.
24. Conboy, I.M. and Rando, T.A. (2002) The regulation of notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell., 3, 397-409.
25. Nijjar, S.S., Wallace, L., Crosby, H.A., Hubscher, S.G. and Strain, A.J. (2002) Altered notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects. Am. J. Pathol., 160, 1695-1703.
26. Lawson, N.D., Scheer, N., Pham, V.N., Kim, C.H., Chitnis, A.B., Campos-Ortega, J.A. and Weinstein, B.M. (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development, 128, 3675-3683.
27. Uyttendaele, H., Closson, V., Wu, G., Roux, F., Weinmaster, G. and Kitajewski, J. (2000) Notch4 and Jagged-1 induce microvessel differentiation of rat brain endothelial cells. Microvasc. Res., 60, 91-103.
28. Hitoshi, S., Alexson, T., Tropepe, V., Donoviel, D., Elia, A.J., Nye, J.S., Conlon, R.A., Mak, T.W., Bernstein, A. and van der Kooy, D. (2002) Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev., 16, 846-858.
29. Jhappan, C., Gallahan, D., Stahle, C., Chu, E., Smith, G.H., Merlino, G. and Callahan, R. (1992) Expression of an activated notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev., 6, 345-355.
30. Nicolas, M., Wolfer, A., Raj, K., Kummer, JA., Mill, P., van Noort, M., Hui, C.C., Clevers, H., Dotto, G.P. and Radtke, F. (2003) Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet., 33, 416-421.
31. Allman, D., Punt, J.A., Izon, D.J., Aster, J.C. and Pear, W.S. (2002) An invitation to T and more: notch signaling in lymphopoiesis. Cell, 109 (suppl.), S1-11.
32. De Smedt, M., Reynvoet, K., Kerre, T., Taghon, T., Verhasselt, B., Vandekerckhove, B., Leclercq, G. and Plum, J. (2002) Active form of notch imposes T cell fate in human progenitor cells. J. Immunol., 169, 3021-3029.
33. Giles, R.H., van Es, J.H. and Clevers, H. (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta, 1653, 1-24.
34. Dahmen, R.P., Koch, A., Denkhaus, D., Tonn, J.C., Sorensen, N., Berthold, F., Behrens, J., Birchmeier, W., Wiestler, O.D. and Pietsch, T. (2001) Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res., 61, 7039-7043.
35. Schilham, M.W., Wilson, A., Moerer, P., Benaissa-Trouw, B.J., Cumano, A. and Clevers, H.C. (1998) Critical involvement of Tcf-1 in expansion of thymocytes. J. Immunol., 161, 3984-3991.
36. Yu, H., Saura, C.A., Choi, S.Y., Sun, L.D., Yang, X., Handler, M., Kawarabayashi, T., Younkin, L., Fedeles, B., Wilson, M.A. et al. (2001) APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron, 31, 713-726.
37. Feng, R., Rampon, C., Tang, Y.P., Shrom, D., Jin, J., Kyin, M., Sopher, B., Martin, G.M., Kim, S.H., Langdon, R.B. et al. (2001) Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron, 32, 911-926.
38. Dewachter, I., Reverse, D., Caluwaerts, N., Ris, L., Kuiperi, C., Van den Haute, C., Spittaels, K., Umans, L., Serneels, L., Thiry, E. et al. (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V7171] transgenic mice. J. Neurosci., 22, 3445-3453.
39. Rozmahel, R., Huang, J., Chen, F., Liang, Y., Nguyen, V., Ikeda, M., Levesque, G., Yu, G., Nishimura, M., Mathews, P. et al. (2002) Normal brain development in PS1 hypomorphic mice with markedly reduced gamma-secretase cleavage of betaAPP. Neurobiol. Aging, 23, 187-194.
40. Qian, S., Jiang, P., Guan, X.M., Singh, G., Trumbauer, M.E., Yu, H., Chen, H.Y., Van de Ploeg, L.H. and Zheng, H. (1998) Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abetal-42/43 expression. Neuron, 20, 611-617.
41. Xia, X., Wang, P., Sun, X, Soriano, S., Shum, WK., Yamaguchi, H., Trumbauer, M.E., Takashima, A., Koo, E.H. and Zheng, H. (2002) The aspartate-257 of presenilin 1 is indispensable for mouse development and production of beta-amyloid peptides through beta-catenin-independent mechanisms. Proc. Natl Acad. Sci. USA, 99, 8760-8765.
42. Kang, D.E., Soriano, S., Xia, X., Eberhart, C.G., De Strooper, B., Zheng, H. and Koo, E.H. (2002) Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell, 110, 751-762.
43. Hager B, Bickenbach J.R. and Fleckman P. (1999) Long-term culture of murine epidermal keratinocytes. J. Invest. Dermatol., 112, 971-976.
44. Cascajo, C.D., Reichel, M. and Sanchez, J.L. (1996) Malignant neoplasms associated with seborrheic keratoses. An analysis of 54 cases. Am. J. Dermatopathol., 18, 278-282.
45. Lo Muzio, L., Pannone, G., Staibano, S., Mignogna, M.D., Grieco, M., Ramires, P., Romito, A.M., De Rosa, G. and Piattelli, A. (2002) WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin. Anticancer Res., 22, 565-576.
46. El-Bahrawy, M., El-Masry, N., Alison, M., Poulsom, R. and Fallowfield, M. (2003) Expression of beta-catenin in basal cell carcinoma. Br. J. Dermatol., 148, 964-970.
47. Saldanha, G., Fletcher, A. and Slater, D.N. (2003) Basal cell carcinoma: a dermatopathological and molecular biological update. Br. J. Dermatol., 148, 195-202.
48. Scolding, N.J. and Joseph, E.G. (2002) The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol. Appl. Neurobiol., 28, 173-189.
49. Mageed, R.A. and Prud'homme, G.J. (2003) Immunopathology and the gene therapy of lupus. Gene Ther., 10, 861-874.
50. Hadland, B.K., Manley, N.R., Su, D., Longmore, G.D., Moore, C.L., Wolfe, M.S., Schroeter, E.H. and Kopan, R. (2001) Gamma-secretase inhibitors repress thymocyte development. Proc. Natl Acad. Sci. USA, 98, 7487-7491.
51. Doerfler, P., Shearman, M.S. and Perlmutter, R.M. (2001) Presenilin-dependent gamma-secretase activity modulates thymocyte development. Proc. Natl Acad. Sci. USA, 98, 9312-9317.
52. Reizis, B. and Leder, P. (2002) Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes Dev., 16, 295-300.
53. Izon, D.J., Punt, J.A. and Pear, W.S. (2002) Deciphering the role of notch signaling in lymphopoiesis. Curr. Opin. Immunol., 14, 192-199.
54. Fowlkes, B.J. and Robey, E.A. (2002) A reassessment of the effect of activated notch1 on CD4 and CD8 T cell development. J. Immunol., 169, 1817-1821.
55. Wilson, A., MacDonald, H.R. and Radtke, F. (2001) Notch1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med., 194, 1003-1012.
56. Wolfe, M.S. (2002) Secretase as a target for Alzheimer's disease. Curr. Top. Med. Chem., 2, 371-383.
57. Wolfe, M.S., Esler, W.P. and Das, C. (2002) Continuing strategies for inhibiting Alzheimer's gamma-secretase. J. Mol. Neurosci., 19, 83-87.
58. Josien, H. (2002) Recent advances in the development of gamma-secretase inhibitors. Curr. Opin. Drug Discov. Devel., 5, 513-525.
59. Micchelli, C.A., Esler, W.P., Kimberly, W.T., Jack, C., Berezovska, O., Kornilova, A., Hyman, B.T., Perrimon, N. and Wolfe, M.S. (2003) Gamma-secretase/presenilin inhibitors for Alzheimer's disease phenocopy notch mutations in Drosophila. FASEB J., 17, 79-81.